Oxygen Saturation Clinical Trial
— IMPROVEOfficial title:
Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal intensiVE Care Patients
Verified date | January 2022 |
Source | Neosense Technologies |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study is a non-blinded trial with one single intervention in sick newborn infants. The Neosense umbilical catheter will be used instead of the routinely used umbilical catheter on infants where the treating physician has ordered use of an umbilical catheter. The catheter will be connected to the Neosense monitor/measuring unit. Blood samples for blood gas analysis are collected from the patients according to the clinical routine (every 4th to 6th hour). Oxygen tension data from the Neosense measuring system, from the time points when a blood gas sample was collected, will be recorded. This data will be compared to the oxygen tension value from the blood gas sample collected at the same time point. The blood gas samples will be analysed according to clinical and laboratory routine. The infants will remain in the study as long as the Neosense measuring system is used.
Status | Terminated |
Enrollment | 6 |
Est. completion date | March 6, 2021 |
Est. primary completion date | March 6, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Sick newborn infants where the clinical routine indicates use of an umbilical catheter. At least one of the criteria below should be fulfilled: - The infant needs invasive measurement of blood pressure. - The infant needs repetitive sampling of blood. - The infant needs prolonged infusion(s) > 2 days. - The infant needs infusion of vessel irritating and potentially vessel harming solutions. - The infant is born extremely preterm (before 28+0 weeks gestational age). - A newborn infant with severe respiratory disorder, requiring oxygen treatment (more than 40% Fraction of inspired oxygen (FiO2)). - The infant is undergoing therapeutic hypothermia following asphyxia ("oxygen deficiency at birth"). - The infant has a severe infection/sepsis. - Signed informed consent form by both parents (or guardians), (if the infant has only one parent (or guardian) one informed consent is required). Exclusion criteria: - Gastroschisis - Omphalocele - Peritonitis - Necrotizing enterocolitis - Omphalitis |
Country | Name | City | State |
---|---|---|---|
Sweden | Karolinska University Hospital | Huddinge | |
Sweden | Uppsala University Children's Hospital | Uppsala |
Lead Sponsor | Collaborator |
---|---|
Neosense Technologies |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Measurement performance of an intravascular oxygen sensor in the Neosense system. | The oxygen tension measured by the Neosense system, compared to the oxygen tension measured by a blood gas analyser. | Average of measurement comparisons done at every blood gas sample, i.e. every 4th - 6th hour during the study (up to 8 days) | |
Secondary | Clinical complications with the Neosense catheter. | The number of occasions when the Neosense catheter had to be removed and the underlying reason. This includes all anticipated device effects as well as placing the catheter in the wrong vessel, impossible to measure blood pressure, collect blood samples and/or administer fluids. | During study, up to 8 days | |
Secondary | Any deviations from normal procedures when inserting an umbilical catheter. | Number of attempts to place the catheter for each patient. Any accessories needed to introduce or handle the Neosense catheter. | During day 1 | |
Secondary | Number of monitor lockups or battery depletions | Timepoint for monitor lockup or battery depletion, in case of occurrence. | During study, in average 4-5 days | |
Secondary | Usability and functionality of the Neosense monitor. | Occurence of anticipated adverse device effects for the monitor. | During study, in average 4-5 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT05995613 -
Evaluation of MABOS for Improved Pulse Oximeter Accuracy in Patients of Color
|
||
Terminated |
NCT05030012 -
Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants
|
N/A | |
Recruiting |
NCT06101641 -
Effect of Shellac Nail Polish Application on Pulse Oximetry Measurements in Healthy Individuals
|
N/A | |
Completed |
NCT03683316 -
Work of Breathing and Kangaroo Mother Care
|
||
Recruiting |
NCT04429906 -
Diagnostic Study of Huami Smart Wearable Device
|
||
Completed |
NCT05784103 -
Comparison of Tissue Oxygenation Measurement Using Multimodal Devices
|
N/A | |
Recruiting |
NCT06283914 -
Imputation of Arterial Oxygen Partial Pressures Using Pulse Oximetry
|
||
Recruiting |
NCT03873298 -
Inhaled NO in IPF and COPD During 6 Minute Walk Test
|
Phase 2 | |
Completed |
NCT03439202 -
Low Intensity Exercise in Different Normobaric/Hypobaric Normoxic/Hypoxic Conditions.
|
N/A | |
Recruiting |
NCT05022264 -
Remote Investigation and Assessment of Vital Signs
|
||
Completed |
NCT02834845 -
Comparison of Volatile Anesthetics on Cerebral Oxygenation During Controlled Hypotension
|
Phase 4 | |
Suspended |
NCT04252547 -
Effect of Kangaroo Care on Test Weighing
|
N/A | |
Completed |
NCT04346498 -
Can Kangarooing Small Babies on the Back of a Mother Keep Them Warm and Stable
|
N/A | |
Completed |
NCT02127333 -
Role of Oxygen for Vascular Dysfunction
|
N/A | |
Not yet recruiting |
NCT05451875 -
Comparison of Continuous Non-invasive All Vital Signs Monitoring Devices With Invasive Gold Standard for Children
|
||
Completed |
NCT05683210 -
Comparison of The Effects of Initial Oral Feeding by Cup and Bottle-Feeding of Preterm Infants
|
N/A | |
Completed |
NCT02017691 -
Cerebral Oxygenation to Guide Supplemental Oxygen
|
Phase 1/Phase 2 | |
Completed |
NCT05709262 -
Comparison of Different Walk and Performance Test in Detecting Silent Hypoxia
|
||
Completed |
NCT05192785 -
The Effects Incentive Spirometry Use in Coronary Artery Bypass Surgery
|
N/A |